Fogarty International Center and National Institute on Drug Abuse in partnership with the Hanoi Medical University
Enhance research development in HIV prevention, treatment and care in the Asia region (Vietnam, China, Cambodia, Laos, Thailand, Burma, Malaysia and Indonesia) in collaboration with US researchers.
Link implementation research efforts in the region with programmatic activities, including those supported by PEPFAR, Global Fund and others.
Provide information on current U.S. National Institutes of Health and other U.S. government opportunities for research, research training, and program implementation.
Identified Priority Research Areas:
Develop better measurements for population-size estimations of drug users and HIV infection rates.
Develop better methodologies to track the changing dynamics of the drug use and HIV epidemics.
Develop integrated models of care for medication assisted treatment and behavioral interventions for drug use combined with HIV Voluntary Counseling and Testing and ART to ensure early diagnosis, comprehensive medical care and transmission prevention.
Develop HIV treatment outreach strategies among drug users as a prevention mechanism, in particular seek, test, treat, and retain models to enhance early detection and treatment to reduce community transmission.
Develop interventions to address treatment and prevention of non-IDU, with a particular focus on ATS.
Develop novel strategies to address bioethical, community and public security issues around designing and implementing studies.
An Asian Interest group has been set up on NIDA's International Virtual Collaboratory (NIVC) web platform. NIVC goals are to facilitate communication among participants, improve access to NIH resources and funding opportunities, enhance the development of research collaborations and research training, and share information regarding trends in HIV, substance abuse epidemiology, prevention, treatment and care, as well as structural and policy changes which may have an impact on in-country and regional drug use research.